Search

Editors

Richard L. Cassin Publisher and Editor

Andy Spalding Senior Editor

Jessica Tillipman Senior Editor

Harry Cassin Managing Editor


Elizabeth K. Spahn Editor Emeritus

Cody Worthington Contributing Editor

Julie DiMauro Contributing Editor

Thomas Fox Contributing Editor

Marc Alain Bohn Contributing Editor

Bill Waite Contributing Editor

Shruti J. Shah Contributing Editor

Russell A. Stamets Contributing Editor

Richard Bistrong Contributing Editor 

Eric Carlson Contributing Editor

Bill Steinman Contributing Editor

Aarti Maharaj Contributing Editor


FCPA Blog Daily News

Entries in China (807)

Thursday
Oct192017

Jerry Fang: China arms corruption fighters with a sharp sword

With the world media attention focused on the 19th National Congress of Chinese Communist Party (CPC), it is worthwhile to pay attention to the nation-wide roll-out of the new anti-corruption regime of the National Supervision Commission (NSC) and introduction of the national supervision law, as just announced by President Xi during his  opening speech.

Click to read more ...

Wednesday
Sep132017

Life Science Alert: China judicial interpretation criminalizes submission of false clinical trial information

A recent judicial interpretation issued by China’s top judicial and prosecutorial bodies now criminalizes submitting falsified nonclinical study or clinical study reports and related materials. This could affect life sciences companies and contract research organizations operating in China.

Click to read more ...

Monday
Sep112017

Carlson and Ma: Revised China commercial bribery rules would broaden offenses and raise penalties

Last week China released for public comment new draft amendments to the Anti-Unfair Competition Law (AUCL), which governs commercial bribery and other acts of unfair competition. 

Click to read more ...

Monday
Aug282017

Thirty-eight new investigations disclosed in 2017

Since the beginning of this year, there have been disclosures about 38 new FCPA-related investigations.

Click to read more ...

Tuesday
Aug222017

OFAC adds Singapore companies, others to North Korea sanctions list

The U.S. Treasury Department's Office of Foreign Assets Control Tuesday put more entities and individuals from China, Russia, Singapore and Namibia on the North Korea sanctions list.

Click to read more ...

Tuesday
Aug082017

MTS Systems says FCPA probes have ended

Minnesota-based MTS Systems Corporation said Monday that FCPA investigations related to China and Korea are complete and the DOJ and SEC aren't bringing enforcement actions.

Click to read more ...

Monday
Jul312017

Jerry Fang: Local Chinese regulator develops anti-bribery management system based on ISO 37001

In June this year, the Market Supervision Commission of the Shenzhen Municipality published an instructive standard document named Anti-bribery Management System Shenzhen Standard to help companies and other organizations prevent bribery, and detect and deal with any bribery that does occur.  

Click to read more ...

Friday
Jul282017

Feds close five-year FCPA probe of IBM

IBM said in an SEC filing that the DOJ and SEC have closed their FCPA investigations into transactions in Argentina, Bangladesh, Poland, and Ukraine.

Click to read more ...

Friday
Jul212017

Andy Spalding on Bhutan: An anti-corruption movement like no other

Bhutan -- the tiny Himalayan kingdom nestled between China and India -- now writes an anti-corruption story unlike any I have seen, and in the best of ways. 

Click to read more ...

Thursday
May182017

China FDA proposals could affect life science industry sales and promotional activities

Late last week, the China Food & Drug Administration released for public comment four draft policy circulars designed to speed approvals for innovative drugs and medical devices, permit conditional approvals for certain products where efficacy has been proven in clinical trials, further protect data exclusivity during clinical trials, allow more flexibility during clinical trials, and clarify IP rights.

Click to read more ...

Friday
Apr282017

South Korea fines Novartis $48 million for doctor kickbacks

South Korea Thursday fined Swiss pharma Novartis $48.3 million for paying doctors kickbacks to prescribe the company's drugs.

Click to read more ...

Thursday
Apr202017

Elizabeth David-Barrett: Pharmas and the repeated failure of anti-bribery compliance

Pharmaceuticals companies continue to fall foul of the FCPA and other anti-bribery laws, with a number of 2016 cases suggesting a vulnerability around marketing practices especially in the Asia-Pacific region. Why does a sector that is way ahead of the compliance game in so many ways keep getting caught out by anti-bribery laws?

Click to read more ...